(3,5-Di-tert-butyl-4-hydroxyphenyl)boronic acid, 97.0%, 1g

7-BROMO-5-CHLORO-INDAN-1-ONE, 95%, 250mg

4-(1-Hydroxyethyl)benzamide, 95.0%, 1g

Trimethyl Citrate>98.0%(GC)25g

6-(Pyridin-3-yloxy)pyridine-3-carboxylic acid, 1g

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, 95%, 250mg

Phase contrast Abbe condenser with slide for Plan PLPHi 20/S100 phase contrast infinity corrected objectives, slide with 20 and 100x phases, telescope and green filter

(E)-3-(4-Amino-3,5-dimethylphenyl)acrylonitrile hydrochloride, 95.0%, 25g

4-[(4-Chlorophenyl)phenylmethyl]-1-piperazineethanol hydrochloride, 5g

3',4'-Difluoropropiophenone, 97.0%, 500g

Glyoxal, 40% w/w aq. soln., 100g

1-Chloro-4H-octafluorobutane, 97.0%, 1g

2-chloro-2-(4-chlorophenyl)acetic acid, 95.0%, 1g